Muhlis Cem Ar

1.3k total citations
113 papers, 655 citations indexed

About

Muhlis Cem Ar is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Muhlis Cem Ar has authored 113 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hematology, 46 papers in Genetics and 24 papers in Oncology. Recurrent topics in Muhlis Cem Ar's work include Chronic Lymphocytic Leukemia Research (29 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Lymphoma Diagnosis and Treatment (16 papers). Muhlis Cem Ar is often cited by papers focused on Chronic Lymphocytic Leukemia Research (29 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Lymphoma Diagnosis and Treatment (16 papers). Muhlis Cem Ar collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Muhlis Cem Ar's co-authors include Zafer Başlar, Ahmet Emre Eşkazan, Teoman Soysal, Ayşe Salihoğlu, Burhan Ferhanoğlu, Kaan Kavaklı, Can Balkan, Şeniz Öngören, Ahmet Murt and Nükhet Tüzüner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Muhlis Cem Ar

89 papers receiving 636 citations

Peers

Muhlis Cem Ar

HEMAT

GENET

ONCOL

EPIDE

Oren Pasvolsky Israel

Masatoshi Sakurai Japan

Mohamad Sobh France

J Kerbauy Brazil

Elvira Deolinda Rodrigues Pereira Velloso Brazil

Jochen Wilpert Germany

Anu Korula India

Francis Lacombe France

Peter Waldron United States

Ana Vidović Serbia

Oren Pasvolsky Israel

Muhlis Cem Ar

337 ×1.0

HEMAT

143 ×0.7

GENET

137 ×1.1

ONCOL

111 ×0.9

49 ×0.6

EPIDE

Citations per year, relative to Muhlis Cem Ar Muhlis Cem Ar (= 1×) peers Oren Pasvolsky

Countries citing papers authored by Muhlis Cem Ar

Since Specialization

Citations

This map shows the geographic impact of Muhlis Cem Ar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhlis Cem Ar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhlis Cem Ar more than expected).

Fields of papers citing papers by Muhlis Cem Ar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhlis Cem Ar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhlis Cem Ar. The network helps show where Muhlis Cem Ar may publish in the future.

Co-authorship network of co-authors of Muhlis Cem Ar

This figure shows the co-authorship network connecting the top 25 collaborators of Muhlis Cem Ar. A scholar is included among the top collaborators of Muhlis Cem Ar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhlis Cem Ar. Muhlis Cem Ar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elverdi, Tuğrul, et al.. (2025). Extramedullary disease in multiple myeloma at diagnosis and over the course of the disease. International Journal of Hematology. 122(1). 73–82.

Çakmakkaya, Özlem Serpil, et al.. (2024). Factors affecting medical students’ satisfaction with online learning: a regression analysis of a survey. BMC Medical Education. 24(1). 11–11. 8 indexed citations

Cho, Sung‐Yeon, Muhlis Cem Ar, Clarisse Martins Machado, et al.. (2023). Epidemiology, treatment patterns, and disease burden of cytomegalovirus in hematopoietic cell transplant recipients in selected countries outside of Europe and North America: A systematic review. Transplant Infectious Disease. 25(4). e14083–e14083. 5 indexed citations

Sonsuz, Abdullah, et al.. (2022). Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders. The Turkish Journal of Gastroenterology. 33(5). 414–420.

Yılmaz, Umut, Tuğrul Elverdi, Ayşe Salihoğlu, et al.. (2022). Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic. Current Problems in Cancer. 46(6). 100913–100913. 1 indexed citations

Yücesan, Emrah, Özden Hatırnaz Ng, Fevzi Yalniz, et al.. (2020). Copy-number variations in adult patients with chronic immune thrombocytopenia. Expert Review of Hematology. 13(11). 1277–1287. 3 indexed citations

Balkan, İ̇lker İnanç, Ayşe Salihoğlu, Yusuf Emre Özdemir, et al.. (2020). An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality. Annals of Hematology. 99(8). 1925–1932. 24 indexed citations

Ar, Muhlis Cem, et al.. (2019). Unilateral Proptosis As An Initial Sign Of Acute Myeloid Leukemia In A Child: A Case Report. SHILAP Revista de lepidopterología. 1 indexed citations

Drelichman, Guillermo, Gilberto Castañeda‐Hernández, Muhlis Cem Ar, et al.. (2019). The road to biosimilars in rare diseases ‐ ongoing lessons from Gaucher disease. American Journal of Hematology. 95(3). 233–237. 9 indexed citations

10.

Erbilgin, Yücel, Ahmet Emre Eşkazan, Özden Hatırnaz Ng, et al.. (2018). Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. Leukemia & lymphoma. 60(1). 200–207. 11 indexed citations

11.

Salihoğlu, Ayşe, Ahmet Emre Eşkazan, Muhlis Cem Ar, et al.. (2017). Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience. Blood. 130. 5349–5349.

12.

Eşkazan, Ahmet Emre, Dilek Keskin, Ayşe Salihoğlu, et al.. (2017). Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study. Blood. 130. 2888–2888.

13.

Büyükaşık, Yahya, İbrahim C. Haznedaroğlu, Gülsüm Özet, et al.. (2017). The Modelled Effectiveness of Ruxolitinib on Survival in Polycythemia Patients with Hydroxyurea Resistance/Intolerance in Turkey. Value in Health. 20(9). A545–A545. 1 indexed citations

14.

Eşkazan, Ahmet Emre, Mahir Cengız, Muhlis Cem Ar, et al.. (2016). Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. Journal of Clinical Pathology. 69(9). 810–816. 3 indexed citations

15.

Zülfikar, Bülent, Kaan Kavaklı, Muhlis Cem Ar, et al.. (2014). A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A Patients. Turkish Journal of Hematology. 31(1). 17–24. 10 indexed citations

16.

Ar, Muhlis Cem, et al.. (2011). Variant Philadelphia translocations with different breakpoints in six chronic myeloid leukemia patients. SHILAP Revista de lepidopterología. 28(3). 186–192. 4 indexed citations

17.

Eşkazan, Ahmet Emre, Şeniz Öngören, Muhlis Cem Ar, et al.. (2011). Essential Thrombocythemia and Multiple Myeloma: Two Rare Diseases in One Patient. Clinical Lymphoma Myeloma & Leukemia. 11(5). 442–445. 9 indexed citations

18.

Ar, Muhlis Cem, Zafer Başlar, Teoman Soysal, et al.. (2009). The Effect of ZAP-70 Expression on Disease Progression in Early-Stage (Binet A) B-CLL Patients. Balkan Medical Journal. 2009(4). 317–321. 1 indexed citations

19.

Öngören, Şeniz, Muhlis Cem Ar, Ahmet Emre Eşkazan, et al.. (2009). Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(2). 321–330. 1 indexed citations

20.

Ng, Özden Hatırnaz, Muhlis Cem Ar, Cemaliye Boylu Akyerli, et al.. (2007). The SOCS‐1 gene methylation in chronic myeloid leukemia patients. American Journal of Hematology. 82(8). 729–730. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact